Related Experiment Video
Updated: Mar 16, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
A Prognostic Indicator for Patients Hospitalized with Heart Failure
Richard Snow1, Karen Vogel1, Bruce Vanderhoff1
1OhioHealth , Columbus, Ohio.
Clinician bias often underestimates patient mortality risk. This study developed a Centers for Medicare and Medicaid Services (CMS) claims data model to identify congestive heart failure (CHF) patients at high risk for six-month mortality, improving hospice and palliative care access.
Area of Science:
- Health Services Research
- Gerontology
- Clinical Informatics
Background:
- Current methods for identifying patients nearing end-of-life are prone to clinician bias, leading to underestimation of mortality risk.
- This results in delayed access to essential hospice and palliative care services for many patients.
Purpose of the Study:
- To develop a prospective prognostic model using Centers for Medicare and Medicaid Services (CMS) claims data.
- The model aims to identify patients with congestive heart failure (CHF) at high risk for six-month mortality.
Main Methods:
- Analysis of CMS claims data from January 1, 2008, to June 30, 2009.
- Inclusion of CHF patients with diagnosis-related groups (DRGs) 291, 292, and 293.
- Univariate and multivariable analyses to identify predictors of six-month mortality, followed by model evaluation for discrimination and calibration.
Main Results:
- The developed prognostic model demonstrated fair discrimination (ROC 0.71) and good calibration (Hosmer-Lemshow statistic 0.98).
- Approximately 5% of discharged CHF patients across all DRGs exhibited a greater than 50% risk of mortality within six months.
Conclusions:
- This prospective claims-data-driven approach can identify CHF patients who may benefit from hospice or palliative care consultations.
- The model offers a more consistent method for matching at-risk patients with appropriate care.
- Further prospective evaluation is needed to confirm clinical utility, impact on referrals, and patient/family benefits.
More Related Videos
04:05Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Related Concept Videos
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure VII: Nursing Interventions
Heart Failure III: Clinical Manifestations
Pathophysiology of Heart Failure
Heart Failure VI: Adjunct Therapies
Heart Failure I: Introduction